583 related articles for article (PubMed ID: 27589847)
1. Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study.
Vissink CE; Huijts SM; de Wit GA; Bonten MJ; Mangen MJ
BMC Infect Dis; 2016 Sep; 16(1):466. PubMed ID: 27589847
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the costs, health status and outcomes in community-acquired pneumonia (CHO-CAP) study in elderly persons hospitalized with CAP.
Mangen MJ; Bonten MJ; de Wit GA
BMC Infect Dis; 2013 Dec; 13():597. PubMed ID: 24354588
[TBL] [Abstract][Full Text] [Related]
3. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.
Rozenbaum MH; Mangen MJ; Huijts SM; van der Werf TS; Postma MJ
Vaccine; 2015 Jun; 33(28):3193-9. PubMed ID: 25981488
[TBL] [Abstract][Full Text] [Related]
4. Treatment costs of community-acquired pneumonia in an employed population.
Colice GL; Morley MA; Asche C; Birnbaum HG
Chest; 2004 Jun; 125(6):2140-5. PubMed ID: 15189934
[TBL] [Abstract][Full Text] [Related]
5. Community-acquired pneumonia: economics of inpatient medical care vis-à-vis clinical severity.
Cupurdija V; Lazic Z; Petrovic M; Mojsilovic S; Cekerevac I; Rancic N; Jakovljevic M
J Bras Pneumol; 2015; 41(1):48-57. PubMed ID: 25750674
[TBL] [Abstract][Full Text] [Related]
6. Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
Webber C; Patton M; Patterson S; Schmoele-Thoma B; Huijts SM; Bonten MJ;
Vaccine; 2017 Mar; 35(9):1266-1272. PubMed ID: 28173960
[TBL] [Abstract][Full Text] [Related]
7. Disease burden of pneumonia in Korean adults aged over 50 years stratified by age and underlying diseases.
Lee JY; Yoo CG; Kim HJ; Jung KS; Yoo KH
Korean J Intern Med; 2014 Nov; 29(6):764-73. PubMed ID: 25378975
[TBL] [Abstract][Full Text] [Related]
8. CAPECO: Cost evaluation of community acquired pneumonia managed in primary care.
Personne V; Chevalier J; Buffel du Vaure C; Partouche H; Gilberg S; de Pouvourville G
Vaccine; 2016 Apr; 34(19):2275-80. PubMed ID: 26979138
[TBL] [Abstract][Full Text] [Related]
9. The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study.
Divino V; Schranz J; Early M; Shah H; Jiang M; DeKoven M
Curr Med Res Opin; 2020 Jan; 36(1):151-160. PubMed ID: 31566005
[No Abstract] [Full Text] [Related]
10. Burden of hospitalized childhood community-acquired pneumonia: A retrospective cross-sectional study in Vietnam, Malaysia, Indonesia and the Republic of Korea.
Tan KK; Dang DA; Kim KH; Kartasasmita C; Kim HM; Zhang XH; Shafi F; Yu TW; Ledesma E; Meyer N
Hum Vaccin Immunother; 2018 Jan; 14(1):95-105. PubMed ID: 29125809
[TBL] [Abstract][Full Text] [Related]
11. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis.
Spoorenberg SM; Bos WJ; Heijligenberg R; Voorn PG; Grutters JC; Rijkers GT; van de Garde EM
BMC Infect Dis; 2014 Jun; 14():335. PubMed ID: 24938861
[TBL] [Abstract][Full Text] [Related]
12. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States.
Kaplan V; Angus DC; Griffin MF; Clermont G; Scott Watson R; Linde-Zwirble WT
Am J Respir Crit Care Med; 2002 Mar; 165(6):766-72. PubMed ID: 11897642
[TBL] [Abstract][Full Text] [Related]
13. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years.
Sato R; Gomez Rey G; Nelson S; Pinsky B
Appl Health Econ Health Policy; 2013 Jun; 11(3):251-8. PubMed ID: 23605251
[TBL] [Abstract][Full Text] [Related]
14. Potential for cost-savings in the care of hospitalized low-risk community-acquired pneumonia patients in China.
Zhou QT; He B; Zhu H
Value Health; 2009; 12(1):40-6. PubMed ID: 18637052
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
[TBL] [Abstract][Full Text] [Related]
16. Burden of community-acquired pneumonia, predisposing factors and health-care related costs in patients with cancer.
Schmedt N; Heuer OD; Häckl D; Sato R; Theilacker C
BMC Health Serv Res; 2019 Jan; 19(1):30. PubMed ID: 30642312
[TBL] [Abstract][Full Text] [Related]
17. Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland.
Keitel K; Alcoba G; Lacroix L; Manzano S; Galetto-Lacour A; Gervaix A
Swiss Med Wkly; 2014; 144():w13925. PubMed ID: 24706389
[TBL] [Abstract][Full Text] [Related]
18. Hospitalization costs of adult community-acquired pneumonia in England.
Campling J; Wright HF; Hall GC; Mugwagwa T; Vyse A; Mendes D; Slack MPE; Ellsbury GF
J Med Econ; 2022; 25(1):912-918. PubMed ID: 35726515
[TBL] [Abstract][Full Text] [Related]
19. Hospitalized low-risk community-acquired pneumonia: outcome and potential for cost-savings.
Hoe LK; Keang LT
Respirology; 1999 Sep; 4(3):307-9. PubMed ID: 10489681
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and costs among seniors requiring hospitalization for community-acquired pneumonia in Alberta.
Carriere KC; Jin Y; Marrie TJ; Predy G; Johnson DH
J Am Geriatr Soc; 2004 Jan; 52(1):31-8. PubMed ID: 14687312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
